questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Lectines
Galectines
Galectine -3
Galectine -3 : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Galectine-3
Tests de laboratoire
Galectine-3
Imagerie médicale
Galectine-3
Analyse d'urine
Symptômes
5
Douleur
Maladies inflammatoires
Symptômes cardiaques
Essoufflement
Prévention
5
Prévention
Mode de vie sain
Exercice physique
Galectine-3
Alimentation
Aliments transformés
Traitements
5
Suppléments alimentaires
Régime alimentaire
Maladies cardiovasculaires
Oncologie
Thérapie génique
Galectine-3
Complications
5
Complications cardiovasculaires
Galectine-3
Insuffisance cardiaque
Galectine-3
Maladies neurodégénératives
Galectine-3
Facteurs de risque
5
Stress chronique
Galectine-3
Maladies auto-immunes
Galectine-3
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Galectine -3 : Questions médicales les plus fréquentes",
"headline": "Galectine -3 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Galectine -3 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-17",
"dateModified": "2025-05-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Galectine -3"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Galectines",
"url": "https://questionsmedicales.fr/mesh/D037161",
"about": {
"@type": "MedicalCondition",
"name": "Galectines",
"code": {
"@type": "MedicalCode",
"code": "D037161",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.503.307"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Galectine -3",
"alternateName": "Galectin 3",
"code": {
"@type": "MedicalCode",
"code": "D037502",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Çiğdem Yücel",
"url": "https://questionsmedicales.fr/author/%C3%87i%C4%9Fdem%20Y%C3%BCcel",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, University of Health Science, Ankara City Hospital, Ankara, Turkey."
}
},
{
"@type": "Person",
"name": "Aybeniz Civan Kahve",
"url": "https://questionsmedicales.fr/author/Aybeniz%20Civan%20Kahve",
"affiliation": {
"@type": "Organization",
"name": "Gazi University Faculty of Medicine, Department of Psychiatry, Ankara, Turkey."
}
},
{
"@type": "Person",
"name": "Işık Batuhan Çakmak",
"url": "https://questionsmedicales.fr/author/I%C5%9F%C4%B1k%20Batuhan%20%C3%87akmak",
"affiliation": {
"@type": "Organization",
"name": "Sungurlu State Hospital, Department of Psychiatry, Corum, Turkey."
}
},
{
"@type": "Person",
"name": "Erol Göka",
"url": "https://questionsmedicales.fr/author/Erol%20G%C3%B6ka",
"affiliation": {
"@type": "Organization",
"name": "University of Health Sciences, Ankara City Hospital, Department of Psychiatry, Ankara, Turkey."
}
},
{
"@type": "Person",
"name": "Massiullah Shafaq-Zadah",
"url": "https://questionsmedicales.fr/author/Massiullah%20Shafaq-Zadah",
"affiliation": {
"@type": "Organization",
"name": "Institut Curie, PSL Research University, U1143 INSERM, UMR3666 CNRS, Cellular and Chemical Biology Unit, 75248Paris Cedex 05, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Molecular information technology with DNA.",
"datePublished": "2023-04-29",
"url": "https://questionsmedicales.fr/article/37127492",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.tibtech.2023.04.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Information technology capability, open technological innovation and firm growth.",
"datePublished": "2023-10-24",
"url": "https://questionsmedicales.fr/article/37874828",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0291227"
}
},
{
"@type": "ScholarlyArticle",
"name": "Information technology improves the quality of transfusion practice in China.",
"datePublished": "2022-12-19",
"url": "https://questionsmedicales.fr/article/36534000",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/vox.13393"
}
},
{
"@type": "ScholarlyArticle",
"name": "College English Multimodal Teaching Based on Digital Information Technology.",
"datePublished": "2022-07-30",
"url": "https://questionsmedicales.fr/article/35942442",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/2911215"
}
},
{
"@type": "ScholarlyArticle",
"name": "The UPPS model of impulsivity in the abuse of Information and Communication Technologies (ICT).",
"datePublished": "2022-07-01",
"url": "https://questionsmedicales.fr/article/33338244",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.20882/adicciones.1449"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lectines",
"item": "https://questionsmedicales.fr/mesh/D037102"
},
{
"@type": "ListItem",
"position": 5,
"name": "Galectines",
"item": "https://questionsmedicales.fr/mesh/D037161"
},
{
"@type": "ListItem",
"position": 6,
"name": "Galectine -3",
"item": "https://questionsmedicales.fr/mesh/D037502"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Galectine -3 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Galectine -3",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Galectine -3",
"description": "Comment mesurer le taux de galectine-3 ?\nQuels tests sont utilisés pour le diagnostic ?\nLa galectine-3 est-elle un biomarqueur ?\nQuels médecins évaluent la galectine-3 ?\nPeut-on détecter la galectine-3 dans l'urine ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Information+Technology#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Galectine -3",
"description": "Quels symptômes sont liés à la galectine-3 ?\nLa galectine-3 cause-t-elle des douleurs ?\nY a-t-il des symptômes cardiaques associés ?\nLa galectine-3 est-elle liée à la fatigue ?\nQuels signes cliniques sont observés ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Information+Technology#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Galectine -3",
"description": "Comment prévenir l'augmentation de la galectine-3 ?\nL'exercice physique influence-t-il la galectine-3 ?\nY a-t-il des aliments à éviter ?\nLe stress affecte-t-il la galectine-3 ?\nDes suppléments peuvent-ils aider à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Information+Technology#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Galectine -3",
"description": "Quels traitements ciblent la galectine-3 ?\nLa galectine-3 peut-elle être traitée par des médicaments ?\nY a-t-il des traitements naturels pour la galectine-3 ?\nLes traitements varient-ils selon la maladie ?\nLa thérapie génique peut-elle cibler la galectine-3 ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Information+Technology#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Galectine -3",
"description": "Quelles complications sont liées à la galectine-3 ?\nLa galectine-3 aggrave-t-elle les maladies ?\nY a-t-il des risques de cancer associés ?\nLa galectine-3 influence-t-elle la fibrose ?\nDes complications neurologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Information+Technology#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Galectine -3",
"description": "Quels facteurs augmentent la galectine-3 ?\nLe tabagisme influence-t-il la galectine-3 ?\nL'âge est-il un facteur de risque ?\nLe stress chronique est-il un facteur de risque ?\nY a-t-il un lien avec les maladies auto-immunes ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Information+Technology#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer le taux de galectine-3 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le taux de galectine-3 se mesure par un test sanguin spécifique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des examens d'imagerie peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "La galectine-3 est-elle un biomarqueur ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est considérée comme un biomarqueur pour certaines maladies."
}
},
{
"@type": "Question",
"name": "Quels médecins évaluent la galectine-3 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cardiologues et oncologues évaluent souvent la galectine-3."
}
},
{
"@type": "Question",
"name": "Peut-on détecter la galectine-3 dans l'urine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La galectine-3 est principalement mesurée dans le sang, pas dans l'urine."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à la galectine-3 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est associée à des symptômes d'inflammation et de fibrose."
}
},
{
"@type": "Question",
"name": "La galectine-3 cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut contribuer à des douleurs liées à des maladies inflammatoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cardiaques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme l'essoufflement peuvent être présents."
}
},
{
"@type": "Question",
"name": "La galectine-3 est-elle liée à la fatigue ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être associée à la fatigue dans des conditions inflammatoires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont observés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'œdème et la dyspnée peuvent être observés."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'augmentation de la galectine-3 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée, peut aider."
}
},
{
"@type": "Question",
"name": "L'exercice physique influence-t-il la galectine-3 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut réduire les niveaux de galectine-3."
}
},
{
"@type": "Question",
"name": "Y a-t-il des aliments à éviter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les aliments transformés et riches en sucres peut être bénéfique."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il la galectine-3 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter les niveaux de galectine-3."
}
},
{
"@type": "Question",
"name": "Des suppléments peuvent-ils aider à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments, comme les oméga-3, peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent la galectine-3 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs de galectine-3 sont en développement pour diverses maladies."
}
},
{
"@type": "Question",
"name": "La galectine-3 peut-elle être traitée par des médicaments ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments visent à réduire son activité dans le corps."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour la galectine-3 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches diététiques et des suppléments peuvent aider à la réguler."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la maladie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements dépendent de la maladie associée à la galectine-3."
}
},
{
"@type": "Question",
"name": "La thérapie génique peut-elle cibler la galectine-3 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches explorent la thérapie génique pour moduler son expression."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à la galectine-3 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est liée à des complications cardiovasculaires et pulmonaires."
}
},
{
"@type": "Question",
"name": "La galectine-3 aggrave-t-elle les maladies ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aggraver des maladies comme l'insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de galectine-3 sont associés à un risque accru de cancer."
}
},
{
"@type": "Question",
"name": "La galectine-3 influence-t-elle la fibrose ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle joue un rôle clé dans le développement de la fibrose tissulaire."
}
},
{
"@type": "Question",
"name": "Des complications neurologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien entre galectine-3 et maladies neurodégénératives."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent la galectine-3 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le diabète et l'inflammation chronique augmentent la galectine-3."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la galectine-3 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque pour des niveaux élevés."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux de galectine-3 augmentent souvent avec l'âge."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à des niveaux élevés de galectine-3."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien avec les maladies auto-immunes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies auto-immunes peuvent augmenter les niveaux de galectine-3."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 12/05/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Biochemistry, University of Health Science, Ankara City Hospital, Ankara, Turkey.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
Gazi University Faculty of Medicine, Department of Psychiatry, Ankara, Turkey.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
Sungurlu State Hospital, Department of Psychiatry, Corum, Turkey.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
University of Health Sciences, Ankara City Hospital, Department of Psychiatry, Ankara, Turkey.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
Institut Curie, PSL Research University, U1143 INSERM, UMR3666 CNRS, Cellular and Chemical Biology Unit, 75248Paris Cedex 05, France.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
Institut Curie, PSL Research University, U1143 INSERM, UMR3666 CNRS, Cellular and Chemical Biology Unit, 75248Paris Cedex 05, France.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
Institut Curie, PSL Research University, U1143 INSERM, UMR3666 CNRS, Cellular and Chemical Biology Unit, 75248Paris Cedex 05, France.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611 ghudalla@bme.ufl.edu.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, University of Health Science, Ankara City Hospital, Ankara, Turkey. rabianazik@gmail.com.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, Elazığ Psychiatric Hospital, Elazığ, Turkey.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, USA 32611. ghudalla@bme.ufl.edu.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Institute of Biostructures and Bioimaging, Consiglio Nazionale Delle Ricerche (CNR), 80134 Naples, Italy.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Institute of Biostructures and Bioimaging, Consiglio Nazionale Delle Ricerche (CNR), 80134 Naples, Italy.
Interuniversity Research Centre on Bioactive Peptides (CIRPEB), University of Naples Federico II, 80134 Naples, Italy.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Interuniversity Research Centre on Bioactive Peptides (CIRPEB), University of Naples Federico II, 80134 Naples, Italy.
Center for Life Sciences and Technologies (CESTEV), University of Naples Federico II, 80145 Naples, Italy.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Via Cinthia 4, 80126 Naples, Italy.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Via Cinthia 4, 80126 Naples, Italy.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Institute of Crystallography, Consiglio Nazionale Delle Ricerche (CNR), 81100 Caserta, Italy.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Institute of Biostructures and Bioimaging, Consiglio Nazionale Delle Ricerche (CNR), 80134 Naples, Italy.
Interuniversity Research Centre on Bioactive Peptides (CIRPEB), University of Naples Federico II, 80134 Naples, Italy.
Publications dans "Galectine -3" :
Qian and Winfree constructed complex biochemical circuits with computation capability from scratch, demonstrating the programmability of biomolecules. One day, programming molecular information proces...
The aim of this paper is to investigate the effects of information technology (IT) capability on firm growth in the context of open technological innovation. The paper utilized a logical deductive app...
Transfusion services in China must establish a quality management system, and regular inspection of quality indicators is an important component of quality management. Although the positive role of in...
We developed an optimized blood transfusion management information system and then analysed the changes in four quality indicators before and after using the system to clarify the role of information ...
After using the optimized system, the completeness rate for transfusion request forms increased from 81.5% to 99.3%; an unqualified doctor's signature was the most common incomplete content (0.45%). T...
Information technology can play an important role in improving the quality of transfusion practice, as part of a programme of medical education, regular audit and other measures....
In the era of in-depth application of knowledge technology in the field of education, the teaching mode combining school English teaching and network data technology is widely used in school English e...
The UPPS model of impulsivity has recently been proposed, has been widely applied to substance abuse and is one of those recommended in the context of Research Domain Criteria, RDoC. However, its appl...
Can the adoption of information technology (IT) by firms drive green innovation and stimulate sustainable development? This paper employs a quasi-natural experiment, namely the "Pilot Zone for Integra...
Development of information and communication technology has been identified as a tool for fast and effective information gathering and dissemination, and as a means through which almost every social a...
Consequently, based on a sample of 38 countries from 2000 to 2018, this study investigates the effect of ICT development on the health gap, and whether the effect varies by gender and sub-region in Af...
The findings of the Driscoll-Kraay standard errors estimation technique supported by those of FGLS and PCSE suggest that ICT does act as an indispensable stimulator for Africa to significantly exceed ...
Information and communication technology (ICT) provides one solution to meet increasing demands for occupational therapy for older adults....
To examine if and how municipality-based occupational therapists (OTs) include ICT in their work, and which factors are associated with use of occupational therapy at a distance....
Survey study including 167 OTs. Data were presented descriptively. Associations were analysed by Chi...
Forty-eight percent of OTs used ICT once a month or more. OTs belief on possibilites to use ICT is associated with replacement of physical home visits. Managers expectations and support also seem to b...
ICT solutions are frequently used by OTs in home health care and can be considered complementing rather than replacing physical home visits. More knowledge is needed on when and how ICT solutions can ...
Access to assistive technologies (ATs) is a human right for people with disabilities, but there are a range of barriers, including lack of adequate information. This review aimed to explore the implic...
Scoping review....
EBSCO Medline, EBSCO Cinahl, Academic Search Ultimate, Business Source Ultimate, Proquest Central, Scopus, Web of Science, PsychINFO, EconLit and JSTOR were searched through 18 July 2021....
Intervention and observational studies and articles directly related to information asymmetry and brokerage in the context of AT were included. In addition, a scan of web-based resources and services ...
Four authors independently screened the articles for inclusion and performed a narrative synthesis....
Thirty-three articles were identified. The narrative synthesis showed that: (1) AT users want access to impartial information sources; (2) users want to be involved in AT selection; (3) users benefit ...
Access to impartial information brokerage is critical to optimise AT selection. The implications of information asymmetry include lower user satisfaction, equipment underutilisation or abandonment. As...
In the medical field, to ensure the use of large medical equipment, it is necessary to carry out regular maintenance on large medical equipment. In the process of maintenance and maintenance of large-...